139 related articles for article (PubMed ID: 22432889)
1. Electrophysiological studies in American Quarter horses with neuroaxonal dystrophy.
Finno CJ; Aleman M; Ofri R; Hollingsworth SR; Madigan JE; Winfield L; Bannasch DL
Vet Ophthalmol; 2012 Sep; 15 Suppl 2():3-7. PubMed ID: 22432889
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of epidemiological, clinical, and pathological features of neuroaxonal dystrophy in Quarter Horses.
Aleman M; Finno CJ; Higgins RJ; Puschner B; Gericota B; Gohil K; LeCouteur RA; Madigan JE
J Am Vet Med Assoc; 2011 Sep; 239(6):823-33. PubMed ID: 21916766
[TBL] [Abstract][Full Text] [Related]
3. Pedigree analysis and exclusion of alpha-tocopherol transfer protein (TTPA) as a candidate gene for neuroaxonal dystrophy in the American Quarter Horse.
Finno CJ; Famula T; Aleman M; Higgins RJ; Madigan JE; Bannasch DL
J Vet Intern Med; 2013; 27(1):177-85. PubMed ID: 23186252
[TBL] [Abstract][Full Text] [Related]
4. Increased α-tocopherol metabolism in horses with equine neuroaxonal dystrophy.
Hales EN; Habib H; Favro G; Katzman S; Sakai RR; Marquardt S; Bordbari MH; Ming-Whitfield B; Peterson J; Dahlgren AR; Rivas V; Ramirez CA; Peng S; Donnelly CG; Dizmang BS; Kallenberg A; Grahn R; Miller AD; Woolard K; Moeller B; Puschner B; Finno CJ
J Vet Intern Med; 2021 Sep; 35(5):2473-2485. PubMed ID: 34331715
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in vitamin E transport genes as determinants for risk of equine neuroaxonal dystrophy.
Ma Y; Peng S; Donnelly CG; Ghosh S; Miller AD; Woolard K; Finno CJ
J Vet Intern Med; 2024; 38(1):417-423. PubMed ID: 37937700
[TBL] [Abstract][Full Text] [Related]
6. Equine neuroaxonal dystrophy/degenerative myeloencephalopathy in Gypsy Vanner horses.
Powers A; Peek SF; Reed S; Donnelly CG; Tinkler S; Gasper D; Woolard KD; Finno CJ
J Vet Intern Med; 2024; 38(3):1792-1798. PubMed ID: 38613444
[TBL] [Abstract][Full Text] [Related]
7. Blood and Cerebrospinal Fluid α-Tocopherol and Selenium Concentrations in Neonatal Foals with Neuroaxonal Dystrophy.
Finno CJ; Estell KE; Katzman S; Winfield L; Rendahl A; Textor J; Bannasch DL; Puschner B
J Vet Intern Med; 2015; 29(6):1667-75. PubMed ID: 26391904
[TBL] [Abstract][Full Text] [Related]
8. Lipid peroxidation biomarkers for evaluating oxidative stress in equine neuroaxonal dystrophy.
Finno CJ; Estell KE; Winfield L; Katzman S; Bordbari MH; Burns EN; Miller AD; Puschner B; Tran CK; Xu L
J Vet Intern Med; 2018 Sep; 32(5):1740-1747. PubMed ID: 30133798
[TBL] [Abstract][Full Text] [Related]
9. Pigment retinopathy in warmblood horses with equine degenerative myeloencephalopathy and equine motor neuron disease.
Finno CJ; Kaese HJ; Miller AD; Gianino G; Divers T; Valberg SJ
Vet Ophthalmol; 2017 Jul; 20(4):304-309. PubMed ID: 27491953
[TBL] [Abstract][Full Text] [Related]
10. Equine Neuroaxonal Dystrophy and Degenerative Myeloencephalopathy.
Finno CJ; Johnson AL
Vet Clin North Am Equine Pract; 2022 Aug; 38(2):213-224. PubMed ID: 35811203
[TBL] [Abstract][Full Text] [Related]
11. Current insights into equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy.
Young AE; Finno CJ
Vet J; 2024 Jun; 305():106129. PubMed ID: 38734404
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide Association Study and Subsequent Exclusion of
Hales EN; Esparza C; Peng S; Dahlgren AR; Peterson JM; Miller AD; Finno CJ
Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31936863
[TBL] [Abstract][Full Text] [Related]
13. Previously Identified Genetic Variants in
Marquardt SA; Wilcox CV; Burns EN; Peterson JA; Finno CJ
Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31491999
[TBL] [Abstract][Full Text] [Related]
14. Equine degenerative myeloencephalopathy in Lusitano horses.
Finno CJ; Higgins RJ; Aleman M; Ofri R; Hollingsworth SR; Bannasch DL; Reilly CM; Madigan JE
J Vet Intern Med; 2011; 25(6):1439-46. PubMed ID: 22092640
[TBL] [Abstract][Full Text] [Related]
15. Serially determined plasma alpha-tocopherol concentrations and results of the oral vitamin E absorption test in clinically normal horses and in horses with degenerative myeloencephalopathy.
Blythe LL; Craig AM; Lassen ED; Rowe KE; Appell LH
Am J Vet Res; 1991 Jun; 52(6):908-11. PubMed ID: 1883094
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histopathological features in horses with neuroaxonal degeneration: 100 cases (2017-2021).
Brown KA; Bender SJ; Johnson AL
J Vet Intern Med; 2024; 38(1):431-439. PubMed ID: 38095342
[TBL] [Abstract][Full Text] [Related]
17. Measurement of 8-hydroxy-2'-deoxyguanosine in serum and cerebrospinal fluid of horses with neuroaxonal degeneration and other causes of proprioceptive ataxia.
Palmisano M; Kulp J; Bender S; Stefanovski D; Robinson M; Johnson A
J Vet Intern Med; 2024; 38(2):1207-1213. PubMed ID: 38205913
[TBL] [Abstract][Full Text] [Related]
18. Serum and cerebrospinal fluid phosphorylated neurofilament heavy protein concentrations in equine neurodegenerative diseases.
Edwards LA; Donnelly CG; Reed SM; Valberg S; Chigerwe M; Johnson AL; Finno CJ
Equine Vet J; 2022 Mar; 54(2):290-298. PubMed ID: 33969539
[TBL] [Abstract][Full Text] [Related]
19. Determination of vitamin E and its metabolites in equine urine using liquid chromatography-mass spectrometry.
Favro G; Habib H; Gennity I; Puschner B; Hales EN; Finno CJ; Moeller BC
Drug Test Anal; 2021 Jun; 13(6):1158-1168. PubMed ID: 33527764
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E depletion is associated with subclinical axonal degeneration in juvenile horses.
Donnelly CG; Finno CJ
Equine Vet J; 2023 Sep; 55(5):884-890. PubMed ID: 36516303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
